You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 45 No. 6, June 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia

H. Szechtman, C. Nahmias, E. S. Garnett, G. Firnau, G. M. Brown, R. D. Kaplan and J. M. Cleghorn
Department of Neurosciences, McMaster University, Hamilton, Ontario, Canada.

This study examines whether the duration of treatment with antipsychotic drugs influences the regional distribution of cerebral [18F]2-fluoro-2-deoxy-D-glucose utilization as measured by positron emission tomography. Two groups of schizophrenic patients are compared with normal volunteers (n = 10). One group (n = 5) consisted of patients treated for one year, and the second (n = 12) of patients medicated for four to 14 years (mean +/- SD duration, 7.4 +/- 3.4 years). The first group was also examined before patients received their first dose ever of antipsychotic medication. One year of medication was not sufficient to alter the schizophrenic profile of cerebral cortical glucose activity but did elevate activity of the corpus striatum. Medication for 7.4 years also did not alter the schizophrenic pattern of frontal hyperactivity and posterior hypoactivity, although deviations from control values appeared less marked than after one year. On the other hand, in patients medicated for 7.4 years, there was perhaps an even greater increase in the activity of the corpus striatum and of the thalamus. Thus, duration of exposure to antipsychotic medication may affect the pattern of cerebral glucose activity; possibly, even longer exposure may contribute to the hypofrontality noted by others, although this can be confounded with the duration of illness as a factor. In considering the biological significance of the observed profile of cortical glucose activity, we introduce the concept of cerebral metabolic tone. We suggest that a disturbance of this tonus may account for some symptoms of schizophrenia and could be consistent with the hypothesis of abnormal developmental changes in the brains of schizophrenics.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effects of Psychotic State and Task Demand on Prefrontal Function in Schizophrenia: An fMRI Study of Overt Verbal Fluency
Fu et al.
Am. J. Psychiatry 2005;162:485-494.
ABSTRACT | FULL TEXT  

Cerebrovascular Response to Cognitive Tasks and Hyperventilation Measured by Multi-Channel Near-Infrared Spectroscopy
Watanabe et al.
J. Neuropsychiatry Clin. Neurosi. 2003;15:442-449.
ABSTRACT | FULL TEXT  

Functional brain mapping of psychopathology
Honey et al.
J. Neurol. Neurosurg. Psychiatry 2002;72:432-439.
ABSTRACT | FULL TEXT  

Three-Dimensional Analysis With MRI and PET of the Size, Shape, and Function of the Thalamus in the Schizophrenia Spectrum
Hazlett et al.
Am. J. Psychiatry 1999;156:1190-1199.
ABSTRACT | FULL TEXT  

Decreased Caudate Volume in Neuroleptic-Naive Psychotic Patients
Keshavan et al.
Am. J. Psychiatry 1998;155:774-778.
ABSTRACT | FULL TEXT  

Cerebral Blood Flow Velocity in Acute Schizophrenic Patients : A Transcranial Doppler Ultrasonography Study
Owega et al.
Stroke 1998;29:1149-1154.
ABSTRACT | FULL TEXT  

Decline of Dopamine: Effects of Age and Acute Neuroleptic Challenge
Am. J. Psychiatry 1998;155:319-323.
FULL TEXT  

Dorsal Striatal Size, Shape, and Metabolic Rate in Never-Medicated and Previously Medicated Schizophrenics Performing a Verbal Learning Task
Shihabuddin et al.
Arch Gen Psychiatry 1998;55:235-243.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.